Top Losers

Catabasis Pharmaceuticals Inc (NASDAQ: CATB) shares tumbled 70.5 percent to $1.20 after the company reported top-line results for Part B of MoveDMD trial for CAT-1004 in DMD. The company disclosed that primary efficacy endpoint was not met. Galena Biopharma Inc (NASDAQ: GALE) shares fell 23....

Tenax Therapeutics Inc (NASDAQ: TENX) shares dropped 76 percent to $0.470 after the company reported top-line results from its Phase 3 LEVO-CTS trial in cardiac surgery. The company disclosed that the trial did not achieve primary endpoints. However, the study met two secondary endpoints....

Ocera Therapeutics Inc (NASDAQ: OCRX) shares dropped 68.3 percent to $0.650 after the company reported top-line results for Phase 2b study in Hepatic Encephalopathy. Regulus Therapeutics Inc (NASDAQ: RGLS) shares declined 50 percent to $1.12 after the company received a written communication...

Novan Inc (NASDAQ: NOVN) shares tumbled 76.4 percent to $4.41 after the company reported top-line results from SB204 Phase 3 pivotal trials. Athersys, Inc. (NASDAQ: ATHX) shares dipped 28.6 percent to $1.09. Athersys reported the pricing of its public offering of 19.8 million common stock at...

Real Goods Solar, Inc. (NASDAQ: RGSE) shares dipped 27.7 percent to $4.06. RGS Energy reported a public offering of common stock and warrants and issued preliminary Q4 results. World Acceptance Corp. (NASDAQ: WRLD) shares tumbled 20.4 percent to $48.11 after the company reported weak Q3...

Meridian Bioscience, Inc. (NASDAQ: VIVO) shares tumbled 24.2 percent to $12.48 after the company reported weak Q1 results and lowered its FY17 guidance. The company also reduced its quarterly dividend to $0.125 per share. Horizon Global Corp (NYSE: HZN) shares dropped 14.2 percent to $17.91...

BT Group plc (ADR) (NYSE: BT) shares dropped 20.8 percent to $19.35 after the company lowered its 2017 and 2018 guidance due to Italian accounting errors. Bioamber Inc (NYSE: BIOA) shares declined 18.6 percent to $4.28. BioAmber increased its previously reported public offering to US$17.5...

Aptose Biosciences Inc (NASDAQ: APTO) shares tumbled 27.4 percent to $0.951 after the company disclosed that it will temporarily delay clinical activities with APTO-253 and will prioritize resources for CG'806 with AML patients. DryShips Inc. (NASDAQ: DRYS) shares dropped 25.7 percent...

Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dipped 22.9 percent to $1.08. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants. Affimed NV (NASDAQ: AFMD) shares fell 20.9 percent to $1.70. Affimed priced its public offering of 10,000,...

DryShips Inc. (NASDAQ: DRYS) shares dipped 27.7 percent to $1.15. DryShips reported a 1-for-8 reverse stock split. Rent-A-Center Inc (NASDAQ: RCII) declined 17.5 percent to $8.40 after the company issued a weak Q4 forecast. GNC Holdings Inc (NYSE: GNC) shares declined 17.2 percent to $9....

EnteroMedics Inc (NASDAQ: ETRM) shares fell 34.8 percent to $5.80. EnteroMedics reported the pricing of $16.5 million underwritten public offering at $5.31 per unit. Pulmatrix Inc (NASDAQ: PULM) shares tumbled 31 percent to $1.07. Pulmatrix shares jumped Tuesday after the company disclosed...

Alcobra Ltd (NASDAQ: ADHD) shares tumbled 54.8 percent to $0.859 after the company disclosed that its Phase 3 trial for MDX has missed the primary endpoint. Christopher & Banks Corporation (NYSE: CBK) shares declined 32.4 percent to $1.42 after the company issued a weak Q4 sales forecast...

Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ: APOP) fell 29.5 percent to $4.31. Cellect Biotechnology shares surged Thursday after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications...

MYOS RENS Technology Inc (NASDAQ: MYOS) shares dropped 43.4 percent to $3.86 after surging 424.62 percent on Wednesday. Fuwei Films (Holdings) Co., Ltd (NASDAQ: FFHL) shares dropped 32.1 percent to $2.56 after surging 97.87 percent on Wednesday. Vista Outdoor Inc (NYSE: VSTO) shares fell...

EnteroMedics Inc (NASDAQ: ETRM) shares dipped 38.6 percent to $17.02 after rising 56.50 percent on Tuesday. Signal Genetics Inc (NASDAQ: SGNL) shares declined 33.6 percent to $11.60 after surging 264.93 percent on Tuesday. ImmunoCellular Therapeutics Ltd (NYSE: IMUC) shares dropped 31.4...